VCYT 8-K 2026-09-14
VERACYTE, INC. (VCYT) 8-K dated 2026-09-14 — accession 0001384101-26-000049.
VERACYTE, INC. (VCYT) is a diagnostics & research company listed on NASDAQ.
VERACYTE, INC. filed a 8-K on 2026-09-14. Accession 0001384101-26-000049.
This 8-K covers: Material agreement (Item 1.01), Acquisition or disposition (Item 2.01), Reg FD disclosure (Item 7.01), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.
Latest reported VCYT revenue for 2025-12-31 was $517.1M. Net income was $66.4M. Revenue was up 16.0% from 2024-12-31 to 2025-12-31. VCYT currently screens at market cap $4.09B and trailing P/E 16.3.
Not investment advice. The VCYT SEC hub lists recent forms. The stock page is the research view.